WestEnd Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98K Hold
10
﹤0.01% 137
2026
Q1
$4.61K Hold
10
﹤0.01% 106
2025
Q4
$5.66K Hold
10
﹤0.01% 99
2025
Q3
$4.47K Sell
10
-6
-38% -$2.88K ﹤0.01% 100
2025
Q2
$8.7K Buy
16
+3
+23% +$1.57K ﹤0.01% 82
2025
Q1
$6.44K Buy
13
+8
+160% +$4.42K ﹤0.01% 87
2024
Q4
$2.61K Buy
5
+1
+25% +$521 ﹤0.01% 94
2024
Q3
$1.97K Hold
4
﹤0.01% 93
2024
Q2
$1.78K Sell
4
-2
-33% -$797 ﹤0.01% 94
2024
Q1
$2.4K Buy
6
+1
+20% +$378 ﹤0.01% 84
2023
Q4
$1.69K Hold
5
﹤0.01% 95
2023
Q3
$1.46K Buy
+5
New +$1.56K ﹤0.01% 90
2023
Q1
Sell
-4
Closed -$985 103
2022
Q4
$1.06K Sell
4
-1
-20% -$244 ﹤0.01% 96
2022
Q3
$1K Buy
5
+1
+25% +$215 ﹤0.01% 116
2022
Q2
$802 Buy
+4
New +$938 ﹤0.01% 119
2022
Q1
Sell
-3
Closed -$876 103
2021
Q4
$1.08K Buy
+3
New +$1.03K ﹤0.01% 104
2021
Q3
Hold
0
179
2021
Q2
Hold
0
100
2013
Q3
Sell
-117
Closed -$6.58K 45
2013
Q2
$6.58K Buy
+117
New +$6.45K ﹤0.01% 43

Other funds holding ISRG

WestEnd Advisors's ISRG Position: Q2 2026 in Review

WestEnd Advisors held its Intuitive Surgical (ISRG) position steady in Q2 2026 at 10 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #137.

WestEnd Advisors first reported a position in ISRG in Q2 2013 and has held it in 17 quarters since. The position peaked at $8.7K in Q2 2025. 2,244 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • WestEnd Advisors held 10 shares of Intuitive Surgical worth $3.98K as of Q2 2026.
  • WestEnd Advisors left its Intuitive Surgical share count unchanged in Q2 2026.
  • Intuitive Surgical made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #137 holding.
  • WestEnd Advisors first reported a position in Intuitive Surgical in Q2 2013 and has held it in 17 quarters since.
  • WestEnd Advisors's Intuitive Surgical position peaked at $8.7K in Q2 2025.
  • 2,244 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.